Northside Capital Management LLC Boosts Stake in GE HealthCare Technologies Inc. $GEHC

Northside Capital Management LLC increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 16.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 163,614 shares of the company’s stock after acquiring an additional 23,107 shares during the quarter. GE HealthCare Technologies comprises 1.2% of Northside Capital Management LLC’s investment portfolio, making the stock its 27th biggest position. Northside Capital Management LLC’s holdings in GE HealthCare Technologies were worth $13,420,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of GEHC. Wedge Capital Management L L P NC purchased a new stake in GE HealthCare Technologies in the 3rd quarter valued at $26,859,000. Valicenti Advisory Services Inc. increased its stake in shares of GE HealthCare Technologies by 22.6% in the 3rd quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock worth $5,115,000 after acquiring an additional 12,550 shares during the last quarter. Temasek Holdings Private Ltd purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter worth $99,922,000. Locust Wood Capital Advisers LLC boosted its position in shares of GE HealthCare Technologies by 7.1% during the 3rd quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock valued at $156,534,000 after acquiring an additional 137,992 shares during the last quarter. Finally, Nan Fung Trinity HK Ltd. purchased a new stake in shares of GE HealthCare Technologies in the third quarter valued at about $23,206,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

GEHC has been the subject of several recent analyst reports. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Jefferies Financial Group increased their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Evercore raised their price target on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their price objective for the company from $73.00 to $77.00 in a report on Thursday, January 15th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Hold” and an average price target of $92.17.

GE HealthCare Technologies Trading Down 1.1%

NASDAQ GEHC opened at $69.61 on Friday. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. The stock has a market capitalization of $31.72 billion, a P/E ratio of 15.26, a PEG ratio of 1.53 and a beta of 1.03. The firm’s 50-day moving average is $79.22 and its two-hundred day moving average is $78.43. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period last year, the business earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.